Eaton Vance Management Deciphera Pharmaceuticals, Inc. Transaction History

Eaton Vance Management

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$32.73 - $47.95 $57,375 - $84,056	-1,753 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$40.39 - $56.73 $70,803 - $99,447	1,753 New	1,753 $79,000
Q3 2020 Nov 13, 2020	SELL	$43.8 - $58.16 $2.25 Million - $2.99 Million	-51,373 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$37.05 - $65.03 $2.72 Million - $4.78 Million	-73,543 Reduced 58.87%	51,373 $3.07 Million
Q1 2020 May 14, 2020	BUY	$33.63 - $69.4 $1.02 Million - $2.11 Million	30,346 Added 32.09%	124,916 $5.14 Million
Q4 2019 Feb 11, 2020	BUY	$31.7 - $69.93 $3 Million - $6.61 Million	94,570 New	94,570 $5.89 Million

293K

500

Ticker DCPH
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 66,822,100
Description
Deciphera Pharmaceuticals, Inc., a biopharmaceutical company, develops drugs to enhance the lives of cancer patients by addressing key mechanisms of drug resistance that limit the rate and durability of response to existing cancer therapies in the United States and internationally. Its lead drug candidate is QINLOCK used for the treatment of gas...

Get notified when there are updates to the investment portfolio of Eaton Vance Management, based on Form 13F filings with the SEC.

Stay updated on Eaton Vance Management with notifications on news.